|
Market Closed -
BME
01:36:49 29/08/26 am AEST
|
After hours 05:59:58 am | |||
| 60.85 EUR | -1.06% |
|
60.88 | +0.04% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +20.9% | 9 | ||||||
| 1,315.04 | +11.81% | 29 | ||||||
| 272.5 | +2.53% | 22 | ||||||
| 276.59 | +7.14% | 29 | ||||||
| 370.31 | +1.73% | 18 | ||||||
| 154.32 | -0.5% | 21 | ||||||
| 212.58 | +29.14% | 22 | ||||||
| 388.48 | -11.1% | 29 | ||||||
| 309.73 | +4.91% | 23 | ||||||
| 157.41 | +5.74% | 27 | ||||||
| 28.61 | +2.09% | 26 | ||||||
| 563.12 | +2.84% | 25 | ||||||
| 66.21 | -1.11% | 24 | ||||||
| 94.28 | +22% | 23 | ||||||
| 21.69 | +17.11% | 20 | ||||||
| 9,350 | +34.59% | 15 | ||||||
| 6,515.81 | +12.17% | 16 | ||||||
| 57.39 | +18.38% | 18 | ||||||
| 71.74 | +50.68% | 17 | ||||||
| 4.214 | +14.05% | 17 | ||||||
| Average | 1,015.22 | +12.26% | 22 | ||||||
| Weighted average by Cap. | 707.48 | +7.94% | 24 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
